Determining health care cost drivers in older Hodgkin lymphoma survivors using interpretable machine learning methods [0.03%]
使用可解释的机器学习方法确定霍奇金淋巴瘤幸存者健康保健费用的主要影响因素
Zasim Azhar Siddiqui,Yves Paul Mbous,Sabina Nduaguba et al.
Zasim Azhar Siddiqui et al.
Background: The cost of health care for patients with Hodgkin lymphoma (HL) is projected to rise, making it essential to understand expenditure drivers across different demographics, including the older adult population. ...
Group-based trajectory modeling to identify longitudinal patterns and predictors of adherence among older adults on concomitant triple therapy (oral antidiabetic, renin-angiotensin-system antagonists, statins) [0.03%]
基于分组轨迹模型来识别联合三联疗法（口服抗糖尿病药，肾素血管紧张素系统拮抗剂，他汀类药物）的老年人中长期依从性模式和预测因素
Sai S Cheruvu,Bilqees Fatima,Susan Abughosh
Sai S Cheruvu
Background: Diabetes, hypertension, and hyperlipidemia frequently co-occur in older adults, significantly increasing their risk for cardiovascular disease, a leading cause of mortality in the United States. Managing these...
Health care resource utilization and direct costs incurred over 12 months by patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibodies: A US real-world study [0.03%]
启动自我注射calcitonin基因相关肽单克隆抗体的偏头痛患者12个月内卫生资源使用及直接花费：一项美国真实世界研究
Oralee J Varnado,Brenna Brady,Anthony Zagar et al.
Oralee J Varnado et al.
Background: Calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) are approved for migraine prevention. Limited information is available comparing the health care resource utilization (HCRU) and direct costs a...
The AMCP Poster Abstract Program provides a forum for authors to share their research with the managed care pharmacy community. Authors submit their abstracts to AMCP, and each abstract is reviewed by a team of peer reviewers and editors. A...
Evaluating the uptake of a Global Initiative for Asthma guideline update in a commercially insured, value-based care population [0.03%]
全球哮喘倡议指南更新在商业保险、基于价值的护理人群中的接受度评估
Lindsey M McInturff,Spenser Smith
Lindsey M McInturff
Background: Asthma is one of the most common chronic respiratory disease states in the United States and poses a large economic burden. The Global Initiative for Asthma updated its clinical guidelines to recommend low-dos...
Use of health technology assessments in specialty drug coverage decisions by US commercial health plans [0.03%]
健康科技评估在美国商业健康计划中专科药物覆盖决策中的应用
Daniel E Enright,Emma G van Duijnhoven,Daniel A Ollendorf et al.
Daniel E Enright et al.
Background: Health technology assessment (HTA) involves a formal review of the clinical, economic, and societal implications of health technologies. Internationally, HTA supports decisions regarding access to novel therap...
Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States [0.03%]
在美国对于免疫性血栓性血小板减少性紫癜患者使用caplacizumab的费用效益分析
Sean D Sullivan,Shruti Chaturvedi,Preety Gautam et al.
Sean D Sullivan et al.
Background: Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening thrombotic microangiopathy. Caplacizumab is the only treatment approved by the European Medicines Agency and the US Food and Drug A...
Real-world adherence to erenumab, rescue medication utilization, and work absenteeism for patients with migraine: Results from an outcomes-based agreement [0.03%]
对于偏头痛患者，实际使用erenumab、抢救药物使用和工作缺勤的情况：来自效果协议的结果
Elizabeth C S Swart,Samuel K Peasah,Yan Huang et al.
Elizabeth C S Swart et al.
Background: Migraine prevalence is estimated to be 15% (approximately 50 million people) in the United States, posing a significant burden on the health care system and a top cause of years lived with disability. Conseque...
The effectiveness and value of disease-modifying therapies for transthyretin amyloid cardiomyopathy [0.03%]
转甲状腺素蛋白淀粉样变性心肌病改良性治疗的有效性和价值
Dmitriy Nikitin,Jason H Wasfy,Aaron N Winn et al.
Dmitriy Nikitin et al.
The impact of patient characteristics and social drivers of health factors on oral oncolytic adherence [0.03%]
患者特征和健康的社会决定因素对口服抗肿瘤药物依从性的影响
Nikki Uyehara,Valerie Nguyen,Stacey Yu et al.
Nikki Uyehara et al.
Background: Oral oncolytic medication adherence is crucial for effective cancer treatment, yet adherence rates vary widely (16%-100%) depending on cancer subtypes, assessment methodologies, and patient contexts. The incre...